Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc3e5cb7a2da33ea01dae32f31bef542 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-715 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-00 |
filingDate |
1999-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8004a42f25c363f7f38399e3071c6a8c |
publicationDate |
2001-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2001002704-A |
titleOfInvention |
Escherichia coli infection inhibitor |
abstract |
(57) [Summary] [Problem] To provide an anti-infective agent for preventing or suppressing infection of Escherichia coli O-157. SOLUTION: An Escherichia coli O-157 infection inhibitor contains ganglioside, particularly ganglioside GM3 and / or ganglioside GD3 as an active ingredient. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011068136-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4677525-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007057334-A |
priorityDate |
1999-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |